These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 350492)

  • 1. 'Patient failure' as a reliability model for the 'minipill': a clinical study.
    Nummi S
    Curr Med Res Opin; 1978; 5(5):406-11. PubMed ID: 350492
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of a synthetic progestogen, ethylnorgestrienone, on hypothalamic-pituitary-ovarian function, cervical mucus, vaginal cytology, and endometrial morphology.
    Niaraki MA; Moghissi KS; Borin K
    Fertil Steril; 1981 Mar; 35(3):284-8. PubMed ID: 6781938
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Temporal relationship between Uniplant insertion and changes in cervical mucus.
    Barbosa IC; Coutinho E; Hirsch C; Ladipo OA; Olsson SE; Ulmsten U
    Contraception; 1996 Oct; 54(4):213-7. PubMed ID: 8922874
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparative randomized trial on the impact of two low-dose oral contraceptives on ovarian activity, cervical permeability, and endometrial receptivity.
    Rossmanith WG; Steffens D; Schramm G
    Contraception; 1997 Jul; 56(1):23-30. PubMed ID: 9306028
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The low dosis gestagen therapy (author's transl)].
    Mall-Haefeli M; Ludwig KS; Spornitz UM; Uettwiller A
    Geburtshilfe Frauenheilkd; 1976 Aug; 36(8):645-60. PubMed ID: 976705
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of a single contraceptive Silastic implant containing nomegestrol acetate on ovarian function and cervical mucus production during 2 years.
    Barbosa I; Coutinho E; Hirsch C; Ladipo O; Olsson SE; Ulmsten U
    Fertil Steril; 1996 Apr; 65(4):724-9. PubMed ID: 8654629
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of daily norethisterone (0.35 mg) on cervical mucus and on urinary LH, pregnanediol and oestrogen levels.
    Elstein M; Briston PG; Hewitt KJ; Kirk D; Miller H
    Br J Obstet Gynaecol; 1976 Feb; 83(2):165-8. PubMed ID: 1032819
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative studies of the ethynyl estrogens used in oral contraceptives. III. Effect on plasma gonadotropins.
    Goldzieher JW; de la Peña A; Chenault CB; Cervantes A
    Am J Obstet Gynecol; 1975 Jul; 122(5):625-36. PubMed ID: 1146928
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of short-term cyclic administration of cyproterone acetate on pituitary-ovarian function in the human.
    Kumari GI; Das RP; Madoiya KK; Jain AK; Roy S
    Fertil Steril; 1977 Nov; 28(11):1168-74. PubMed ID: 562781
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of norgestimate in combination with ethinyl estradiol on cervical mucus.
    Mohsenian M; Moghissi KS; Borin K
    Contraception; 1981 Aug; 24(2):173-81. PubMed ID: 7297068
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical investigation of the biological effects of a new combination low-dose oral contraceptive ('Ovostat E').
    Tarkkila T; Hulkko S; Alapiessa U; Kauraniemi T
    Curr Med Res Opin; 1977; 5(3):247-51. PubMed ID: 162661
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Urinary hormone excretion patterns during low-dose progestogen administration.
    Varga L; Tamme E
    J Int Med Res; 1975; 3(2):63-72. PubMed ID: 1140508
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interference with ovulation by sequential treatment with the antiprogesterone RU486 and synthetic progestin.
    Kekkonen R; Alfthan H; Haukkamaa M; Heikinheimo O; Luukkainen T; Lähteenmäki P
    Fertil Steril; 1990 Apr; 53(4):747-50. PubMed ID: 2108063
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Current status of antagonistic analogs of LH-RH as a contraceptive method in the female.
    Schally AV
    Res Front Fertil Regul; 1983 Jul; 2(5):1-16. PubMed ID: 12179624
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunoglobulins, proteinase inhibitors, albumin, and lysozyme in human cervical mucus. I. Communication: hormonal profiles and cervical mucus changes--methods and results.
    Schumacher GF; Kim MH; Hosseinian AH; Dupon C
    Am J Obstet Gynecol; 1977 Nov; 129(6):629-36. PubMed ID: 72503
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlation of plasma gonadotrophins and ovarian steroids pattern with symptomatic changes in cervical mucus during the menstrual cycle in normal cycling women.
    Cortesi S; Rigoni G; Zen F; Sposetti R
    Contraception; 1981 Jun; 23(6):629-41. PubMed ID: 6793304
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cervical mucus peroxidase is a reliable indicator for ovulation in humans.
    Anderson WA; Ahluwalia BS; Westney LS; Burnett CC; Rüchel R
    Fertil Steril; 1984 May; 41(5):697-702. PubMed ID: 6325254
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prediction and detection of ovulation.
    Moghissi KS
    Fertil Steril; 1980 Aug; 34(2):89-98. PubMed ID: 6773821
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sequential regimen of the antiprogesterone RU486 and synthetic progestin for contraception.
    Kekkonen R; Lähteenmäki P; Luukkainen T; Tuominen J
    Fertil Steril; 1993 Oct; 60(4):610-5. PubMed ID: 8405512
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cervical mucus and prediction of the time of ovulation.
    Morishita H; Hashimoto T; Mitani H; Tanaka T; Higuchi K; Ozasa T
    Gynecol Obstet Invest; 1979; 10(4):157-62. PubMed ID: 527887
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.